Serina Therapeutics (SER) EPS (Basic) Growth (1y) (2019 - 2026)
Serina Therapeutics (SER) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | -16.29% |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 16.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.93% |
| Dec 31, 2025 | 22.04% |
| Sep 30, 2025 | -1.17% |
| Jun 30, 2025 | 99.89% |
| Mar 31, 2025 | 40.11% |
| Dec 31, 2024 | -100.20% |
| Sep 30, 2024 | 99.96% |
| Jun 30, 2024 | 46.06% |
| Mar 31, 2024 | -10.85% |
| Dec 31, 2023 | 24,505.71% |
| Sep 30, 2023 | -64,050.97% |
| Jun 30, 2023 | 59.78% |
| Mar 31, 2023 | 61.29% |
| Sep 30, 2022 | -34,692.65% |
| Jun 30, 2022 | -37,383,462.37% |
| Mar 31, 2022 | -2,513.40% |
| Sep 30, 2021 | 99.98% |
| Jun 30, 2021 | 102.32% |
| Mar 31, 2021 | 99.93% |
| Dec 31, 2020 | 89.39% |